Interferon β-1a subcutaneously 3 times/week clinical outcome in relapsing multiple sclerosis in Finland von Järvinen, Elina, Murtonen, Annukka, Tervomaa, Melina, Sumelahti, Marja-Liisa

Volltext

Increased Female MS Incidence and Differences in Gender-Specific Risk in Medium- and High-Risk Regions in Finland from 1981-2010 von Sumelahti, Marja-Liisa, Elovaara, Irina, Murtonen, Annukka, Holmberg, Markus

Volltext

Increasing Incidence in Relapsing-Remitting MS and High Rates among Young Women in Finland: A Thirty-Year Follow-Up von Huhtala, Heini, Murtonen, Annukka, Holmberg, Markus, Sumelahti, Marja-Liisa, Elovaara, Irina

Volltext

Multiple sclerosis prevalence in 2000 and 2010 in Western Finland von Murtonen, Annukka, Sumelahti, Marja‐Liisa

Volltext

End of life in multiple sclerosis: Disability, causes and place of death among cases diagnosed from 1981 to 2010 in Pirkanmaa hospital district in Western Finland von Murtonen, Annukka, Lehto, Juho T., Sumelahti, Marja-Liisa

Volltext

Changes in multiple sclerosis epidemiology in Finland over five decades von Pirttisalo, Anna‐Leena, Soilu‐Hänninen, Merja, Sumelahti, Marja‐Liisa, Krökki, Olga, Murtonen, Annukka, Hänninen, Katariina, Sipilä, Jussi O. T.

Volltext